From the Journals

Respiratory infections in early years of life linked to celiac disease


 

FROM PEDIATRICS

The frequency of respiratory infections in the first 2 years of life could distinguish children who will develop celiac disease (CD) from those who will not in those with a family history of CD, according to Renata Auricchio, MD, University of Naples (Italy) Federico II, and her associates.

In a prospective cohort study, 373 newborns from families with at least one relative with CD were recruited. The cumulative incidence of new cases of CD was 6% at 3 years and 13.5% at 5 years of age, the researchers noted. In the first year when no child produced anti-tissue transglutaminase (anti-tTG) antibodies, respiratory infections (upper and lower tract) were more common among the case patients than among the controls (58% vs. 40%). During the second year, respiratory infections were again more frequent among the case patients than among controls (52% vs. 32%). And in the third year of life when most of the case patients were diagnosed with CD, no clinical event was more frequent in the case patients than in the control group.

designer491/Thinkstock
In a multivariate analysis, the researchers found that only respiratory infections in the second year of life were associated with a twofold increase in the risk of developing CD (odds ratio, 2.25; P = .04). The second variable was respiratory infections in the first year of life, which had a score of 1.58. Results from the stepwise discriminant analysis suggested respiratory infections in the first and second years of life significantly contributed to the index of discrimination between the case patients and the controls.

“In this study, we report that early infections significantly contribute to the risk of developing CD,” Dr. Auricchio and her associates concluded. “It is possible that the exposure to early infection stimulates a genetically predisposed immune profile, which contributes to the switch from tolerance to intolerance to gluten, which is a common food antigen.”

Read the full study in Pediatrics (doi: 10.1542/peds.2016-4102).

Recommended Reading

FDA grants accelerated approval for treatment of Chagas disease in children
MDedge Infectious Disease
Developing vaccines against enterovirus-A71 called a priority
MDedge Infectious Disease
FDA approves Vabomere for complicated UTI in adults
MDedge Infectious Disease
In California, medical vaccine exemptions tripled after personal belief exemption ban
MDedge Infectious Disease
Light alcohol use did not affect liver fibrosis progression in HIV/HCV-coinfected women
MDedge Infectious Disease
Enhanced disinfection of duodenoscopes did not reduce contamination
MDedge Infectious Disease
Q&A: CDC director Brenda Fitzgerald stresses ‘science and service’
MDedge Infectious Disease
Burden of HCV-induced cirrhosis expected to shift from men to women
MDedge Infectious Disease
Vaccinate and consider tofacitinib monotherapy to prevent herpes zoster in RA
MDedge Infectious Disease
Zika’s 2017 summer less active than 2016
MDedge Infectious Disease